Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cortisol Blockade in Metabolic Syndrome
NCT01620684Phase 4Unknown
- Sponsor
- Baker Heart and Diabetes Institute
- Start
- Feb 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metyrapone in metabolic syndrome, obesity, sponsored by Baker Heart and Diabetes Institute. Status: unknown.
02
Drugs
metyrapone
03
Conditions
metabolic syndromeobesity
Beyond the preview
Go deeper on NCT01620684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01620684.